Zobrazeno 1 - 10
of 46
pro vyhledávání: '"LISE HOBOLTH"'
Autor:
Malene Barfod O’Connell, Anne Brødsgaard, Maria Matthè, Lise Hobolth, Laus Wullum, Flemming Bendtsen, Nina Kimer
Publikováno v:
Hepatology Communications, Vol 8, Iss 5 (2024)
Background:. Few randomized trials have evaluated the effect of postdischarge interventions for patients with liver cirrhosis. This study assessed the effects of a postdischarge intervention on readmissions and mortality in patients with decompensate
Externí odkaz:
https://doaj.org/article/8ef8095587594785acd1eaf898870fa4
Autor:
Thit Mynster Kronborg, Henry Webel, Malene Barfod O’Connell, Karen Vagner Danielsen, Lise Hobolth, Søren Møller, Rasmus Tanderup Jensen, Flemming Bendtsen, Torben Hansen, Simon Rasmussen, Helene Bæk Juel, Nina Kimer
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract The inflammatory activity in cirrhosis is often pronounced and related to episodes of decompensation. Systemic markers of inflammation may contain prognostic information, and we investigated their possible correlation with admissions and mor
Externí odkaz:
https://doaj.org/article/5e2f8afd3541470ea9a07866dca3ca25
Autor:
Josephine Grandt, Anne‐Sofie H. Jensen, Mikkel P. Werge, Elias B. Rashu, Andreas Møller, Anders E. Junker, Lise Hobolth, Christian Mortensen, Christian D. Johansen, Mogens Vyberg, Reza Rafiolsadat Serizawa, Søren Møller, Lise Lotte Gluud, Nicolai J. Wewer Albrechtsen
Publikováno v:
Physiological Reports, Vol 11, Iss 8, Pp n/a-n/a (2023)
Abstract Fatty liver disease has mainly been characterized under fasting conditions. However, as the liver is essential for postprandial homeostasis, identifying postprandial disturbances may be important. Here, we investigated postprandial changes i
Externí odkaz:
https://doaj.org/article/5b92858c4b1641adbc65716474f5fd74
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Liver cirrhosis is a disease characterised by multiple complications and a poor prognosis. The prevalence is increasing worldwide. Chronic inflammation is ongoing in liver cirrhosis. No cure for the inflammation is available, and the current treatmen
Externí odkaz:
https://doaj.org/article/0ebebb3ac8cc4cbd9a319be99cd06146
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220697 (2019)
BackgroundThe soluble urokinase plasminogen activator receptor (suPAR) is related to hepatic inflammation and fibrosis and has been suggested to participate in the development of liver cirrhosis. Therefore, the aim of the current study was to measure
Externí odkaz:
https://doaj.org/article/09b14f0663994ff187d2edbc81f0446e
Autor:
Nina Kimer, Agnete Nordheim Riedel, Lise Hobolth, Christian Mortensen, Lone Galmstrup Madsen, Mette Lehmann Andersen, Frank Vinholt Schiødt, Søren Møller, Lise Lotte Gluud
Publikováno v:
Medicina, Vol 56, Iss 11, p 565 (2020)
Background and objectives: Refractory ascites markedly worsens prognosis in cirrhosis. Large volume paracentesis (LVP) is standard treatment, but complications are common. In a randomized controlled case-series, we assessed a permanent tunneled perit
Externí odkaz:
https://doaj.org/article/1795eee8c4474a22a5860cc8ecf61465
Autor:
Josephine Grandt, Christian D. Johansen, Anne-Sofie H. Jensen, Mikkel P. Werge, Elias B. Rashu, Andreas Møller, Anders E. Junker, Lise Hobolth, Christian Mortensen, Mogens Vyberg, Reza Rafiolsadat Serizawa, Søren Møller, Lise Lotte Gluud, Nicolai Jacob Wewer Albrechtsen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3daa9f8ac83a9eff98edc7f48e3551a9
https://doi.org/10.2139/ssrn.4427001
https://doi.org/10.2139/ssrn.4427001
Autor:
Signe Bollerup, Sofie Hallager, Frederik Engsig, Amanda Mocroft, Henrik Krarup, Lone G. Madsen, Peter Thielsen, Ulla Balslev, Helene Mens, Toke S. Barfod, Mette R. Clausen, Lise Hobolth, Alex L. Laursen, Britta Tarp, Birgit T. Roege, Jesper B. Hansen, Lone Mygind, Peer B. Christensen, Jan Gerstoft, Nina Weis
Publikováno v:
Bollerup, S, Hallager, S, Engsig, F, Mocroft, A, Krarup, H, Madsen, L G, Thielsen, P, Balslev, U, Mens, H, Barfod, T S, Clausen, M R, Hobolth, L, Laursen, A L, Tarp, B, Roege, B T, Hansen, J B, Mygind, L, Christensen, P B, Gerstoft, J & Weis, N 2022, ' Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in Denmark ', Journal of Viral Hepatitis, vol. 29, no. 9, pp. 727-736 . https://doi.org/10.1111/jvh.13713
The study aimed to determine adjusted all-cause mortality and cause of death in persons with chronic hepatitis B virus (HBV) infection compared with age- and sex-matched persons from the general population. We used nationwide registers to identify pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56ab7ceffcc1284974918b7b4630c0a7
https://vbn.aau.dk/ws/files/532536921/Mortality_and_cause_of_death_in_persons_with_chronic_hepatitis_B_virus_infection_versus_healthy_persons_from_the_general_population_in_Denmark.pdf
https://vbn.aau.dk/ws/files/532536921/Mortality_and_cause_of_death_in_persons_with_chronic_hepatitis_B_virus_infection_versus_healthy_persons_from_the_general_population_in_Denmark.pdf
Autor:
Nina Kimer, Lise Hobolth
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 56(1)
Autor:
JOSEPHINE GRANDT, ANNE-SOFIE H. JENSEN, MIKKEL P. WERGE, ELIAS B. RASHU, ANDERS JUNKER, LISE HOBOLTH, CHRISTIAN MORTENSEN, MOGENS VYBERG, REZA SERIZAWA, SØREN MØLLER, LISE GLUUD, NICOLAI J. WEWER ALBRECHTSEN
Publikováno v:
Diabetes. 71
Metabolic dysfunction in patients with metabolic fatty liver disease (MAFLD) may increase the risk for diabetes development. The liver is essential for the postprandial control of our metabolism and hormonal response, yet most studies focus on fastin